ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Visceral Arterial Embolization – An Important Tool For Managing Blood Loss In Multivisceral Transplant Candidates With Portomesenteric Thrombosis

D. P. Borle, J. A. Shah, R. Kadiyala Venkata, D. Vikraman, B. Collins, S. Knechtle, A. Rege, A. Barbas, C. Kim, T. Smith, P. Sohocki, D. L. Sudan

Duke University Medical Center, Durham, NC

Meeting: 2019 American Transplant Congress

Abstract number: 521

Keywords: Blood transfusion, Intra-abdominal infection, Ischemia, Multivisceral transplantation

Session Information

Session Name: Concurrent Session: Small Bowel

Session Type: Concurrent Session

Date: Tuesday, June 4, 2019

Session Time: 2:30pm-4:00pm

 Presentation Time: 3:42pm-3:54pm

Location: Room 209

*Purpose: Organ explant in multivisceral transplant (MVT) candidates is technically demanding associated with high volume blood loss. Visceral arterial embolisation (VAE) may reduce bleeding, but limited experience in MVT has been reported

*Methods: Between June 2015 and Nov 2018 MVT candidates with complete PMT were identified who underwent VAE before or during transplant. Clinical characteristics, intraoperative variables and outcomes were reviewed

*Results: Median recipient age was 44 (40-55) years; 60% were men. Indication for MVT was cirrhosis with PMT precluding isolated liver transplantation. Median MELD was 26 (21-37). Interventional radiologists performed VAE immediately prior to MVT in 4 and intraperatively (after initial attempts at explantation of native viscera) in 1 with interlock coils, Amplatzer plug and gelgoam with or without Trufill glue and Lipiodol including splenic and superior mesenteric arteries in 5; while common hepatic, celiac axis and gasproduodenal artery were embolized in 3,3 and 1 patients respectively. Median blood loss was 6000 (800-7000) ml. Transfusion requirements were: red blood cell 16 (2-47) units, fresh frozen plasma 14 (0-29) units, cryoprecipitate 2 (1-14) units, platelets 4 (2-10) units. Advantage of VAE was clear in 2 cases: in patient undergoing intraoperative VAE, there was markedly improved hemodynamic stability, decreased vasopressor requirement and blood loss after embolisation. In a second patient, incomplete occlusion of arterial flow due to challenging vascular anatomy was associated with large volume blood loss (47 units of red cell transfusion). Time from incision to explant was 420 (198-490) min. Median lactate values pre-,post-VAE and at end of surgery were 4.1 (2.1-10.1), 5.8 (3.1-10.6), 4.2 (2.4-6.3) respectively. No correlation was identified between lactate level and length of the explant, transfusion volume, vasopressor use or postoperative infections. In 2 out of the 5 patients infection with multiple atypical organisms including non Tuberculous Mycobacteria and various Candida species were identifies; 1 of the 2 died. Both patients had prolonged cold schema times (557 and 474 min) compared to recipients who did not develop infections (average 347 min)

*Conclusions: MVT in candidates with PMT is associated with large volume blood loss and hemodynamic instability which can be improved with VAE. Further studies are needed however to determine the contribution of native gut necrosis, to the occurrence of potentially life-threatening atypical infections.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Borle DP, Shah JA, Venkata RKadiyala, Vikraman D, Collins B, Knechtle S, Rege A, Barbas A, Kim C, Smith T, Sohocki P, Sudan DL. Visceral Arterial Embolization – An Important Tool For Managing Blood Loss In Multivisceral Transplant Candidates With Portomesenteric Thrombosis [abstract]. Am J Transplant. 2019; 19 (suppl 3). https://atcmeetingabstracts.com/abstract/visceral-arterial-embolization-an-important-tool-for-managing-blood-loss-in-multivisceral-transplant-candidates-with-portomesenteric-thrombosis/. Accessed May 18, 2025.

« Back to 2019 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences